Zhou Feng, Fu Jinhua, Wu Nanzhen, Liu Yang, Xie Yong, Zhou Xiaojiang
Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Department of Gastrointestinal Surgery, Fengcheng People's Hospital, Fengcheng, Jiangxi, China.
Heliyon. 2024 Jul 25;10(15):e35076. doi: 10.1016/j.heliyon.2024.e35076. eCollection 2024 Aug 15.
The COVID-19 pandemic had a substantial impact on cancer services. The aim of our study was to evaluate the recovery of endoscopic activity and cancer detection after the COVID-19 pandemic.
Endoscopic data from January 2019 to December 2020 were retrospectively collected to assess the endoscopic activity and cancer detection during the COVID-19 peak period (February 2020) and the post-COVID-19 peak period (March to July 2020).
The COVID-19 pandemic almost brought endoscopic activity and cancer detection to a standstill. Diagnostic procedure and endoscopic resection showed the greatest reduction. With the decline in COVID-19 infections, endoscopic activity gradually returned to previous level in July. However, the detection rate of gastric cancer resumed in September, whereas colorectal cancer resumed in August. The monthly detection rates of gastric and colorectal cancers decreased from their initial peaks of 2.98 % and 6.45 %, respectively, and finally were even lower than the average in 2019. Similarly, the mean age of patients who received endoscopy also declined as the detection rates resumed. The increasing colonoscopies allowed the missing colorectal cancer patients to be caught up. In contrast, it was expected that 6.69 % of gastric cancer patients were missed and did not receive needed endoscopy.
The recovery of cancer detection occurred later than that of endoscopic activity, especially for gastric cancer. Older people were vulnerable to the continuous impact of COVID-19 pandemic than young people for seeking medical services. Urgent efforts are required to recover and maintain cancer services before subsequent waves of the COVID-19 pandemic.
新冠疫情对癌症服务产生了重大影响。我们研究的目的是评估新冠疫情后内镜检查活动和癌症检测的恢复情况。
回顾性收集2019年1月至2020年12月的内镜检查数据,以评估新冠疫情高峰期(2020年2月)和新冠疫情高峰期后(2020年3月至7月)的内镜检查活动和癌症检测情况。
新冠疫情几乎使内镜检查活动和癌症检测陷入停滞。诊断程序和内镜切除的减少最为显著。随着新冠感染人数的下降,内镜检查活动在7月逐渐恢复到先前水平。然而,胃癌的检测率在9月恢复,而结直肠癌的检测率在8月恢复。胃癌和结直肠癌的月度检测率分别从最初的峰值2.98%和6.45%下降,最终甚至低于2019年的平均水平。同样,接受内镜检查的患者的平均年龄也随着检测率的恢复而下降。结肠镜检查数量的增加使得漏诊的结直肠癌患者得以被发现。相比之下,预计有6.69%的胃癌患者漏诊,未接受必要的内镜检查。
癌症检测的恢复比内镜检查活动的恢复要晚,尤其是胃癌。在寻求医疗服务方面,老年人比年轻人更容易受到新冠疫情持续影响。在后续新冠疫情浪潮到来之前,迫切需要努力恢复和维持癌症服务。